Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tirtha Chakraborty

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|May 6, 2009
A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activationTirtha Chakraborty, Thomas Perlot, Ramesh Subrahmanyam, et al.
Nature Immunology|October 30, 2012
Localized epigenetic changes induced by DH recombination restricts recombinase to DJH junctionsRamesh Subrahmanyam, Hansen Du, Irina Ivanova, et al.
Frontiers in Immunology|November 28, 2022
miR-142 favors naïve B cell residence in peripheral lymph nodesMagdalena Hagen, Tirtha Chakraborty, William J Olson, et al.
Cell|March 11, 2008
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineageSergei B Koralov, Stefan A Muljo, Gunther R Galler, et al.
Nucleic Acid Therapeutics|August 9, 2018
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-DestructRuchi Jain, Josh P Frederick, Eric Y Huang, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Erratum: Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
Cell|February 21, 2012
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse modelBaochun Zhang, Sven Kracker, Tomoharu Yasuda, et al.
Genes & Development|November 9, 2019
Context-specific regulation of cell survival by a miRNA-controlled BIM rheostatVerena Labi, Siying Peng, Filippos Klironomos, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|May 6, 2009
A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activationTirtha Chakraborty, Thomas Perlot, Ramesh Subrahmanyam, et al.
Nature Immunology|October 30, 2012
Localized epigenetic changes induced by DH recombination restricts recombinase to DJH junctionsRamesh Subrahmanyam, Hansen Du, Irina Ivanova, et al.
Frontiers in Immunology|November 28, 2022
miR-142 favors naïve B cell residence in peripheral lymph nodesMagdalena Hagen, Tirtha Chakraborty, William J Olson, et al.
Cell|March 11, 2008
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineageSergei B Koralov, Stefan A Muljo, Gunther R Galler, et al.
Nucleic Acid Therapeutics|August 9, 2018
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-DestructRuchi Jain, Josh P Frederick, Eric Y Huang, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Erratum: Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
Cell|February 21, 2012
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse modelBaochun Zhang, Sven Kracker, Tomoharu Yasuda, et al.
Genes & Development|November 9, 2019
Context-specific regulation of cell survival by a miRNA-controlled BIM rheostatVerena Labi, Siying Peng, Filippos Klironomos, et al.
Pageof 3